The proposal focuses on the role of muscarinic receptor subtypes, as defined by ligand specificity and selectivity for second messenger systems, in the regulation of cholinergic systems. The effects of acute and long-term administration of muscarinic agents will be examined through autoradiographic measures of receptor binding and by monitoring behavioral changes associated with receptor adaption. Experiments are designed to determine the relative contribution of M1 and M2 receptors to receptor upregulation and downregulation respectively. This will be accomplished by measuring the effects of exposures to pirenzepine, gallamine and AFDX-116 on the number and affinity of muscarinic receptors through autoradiographic methods. Downregulation of muscarinic receptors by increased levels of acetylcholine is expected to develop following long-term exposure to presynaptic antagonists such as gallamine, while pirenzepine will cause upregulation. The regulation of muscarinic receptors by acetylcholine is an important consideration for long-term treatment of cholinergic disorders. Recent advances in the treatment of Alzheimer's disease focus on the use of cholinesterase inhibitors to elevate levels of acetylcholine. In this regard, it is necessary to determine if selective or partial agonists also induce a decrease in muscarinic receptors. The development of agents which activate muscarinic receptors without inducing receptor downregulation may provide effective, prolonged treatment for Alzheimer's patients. The effects of partial agonists on performance of a behavioral task dependent on memory will provide an in vivo measure of cholinergic activity. The selectivity of partial agonists for muscarinic receptor second messenger systems provides a rational approach for activation of the muscarinic receptors important for memory function, without interfering with receptor involved in receptor down-regulation or desensitization. Taken together, the experiments will determine the role of muscarinic receptor subtypes in the regulation of receptor number. Regulation will be measured first by the use of selective antagonists and then by selective agonists. The results from both neurochemical and behavioral assays will provide important information relating muscarinic receptor regulation to behavior adaptation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS025765-03
Application #
3411190
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1988-02-01
Project End
1992-01-31
Budget Start
1990-02-01
Budget End
1992-01-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Toledo
Department
Type
Schools of Pharmacy
DUNS #
City
Toledo
State
OH
Country
United States
Zip Code
43606
Dunbar, P G; Durant, G J; Rho, T et al. (1994) Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists. J Med Chem 37:2774-82
Dunbar, P G; Durant, G J; Fang, Z et al. (1993) Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists. J Med Chem 36:842-7
Collins, D; Smith, D A; Messer Jr, W S (1993) Regional binding of 4-diphenylacetoxy-N-methylpiperidine methobromide (4-DAMP) to muscarinic receptors in rat brain and comparative analysis of minimum energy conformations. Neurochem Int 22:237-47
Patel, P J; Messer Jr, W S; Hudson, R A (1993) Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs. J Med Chem 36:1893-901
Messer Jr, W S; Ngur, D O; Abuh, Y F et al. (1992) Stereoselective binding and activity of oxotremorine analogs at muscarinic receptors in rat brain. Chirality 4:463-8
Ngur, D; Roknich, S; Mitch, C H et al. (1992) Steric and electronic requirements for muscarinic receptor-stimulated phosphoinositide turnover in the CNS in a series of arecoline bioisosteres. Biochem Biophys Res Commun 187:1389-94
Messer Jr, W S; Stibbe, J R; Bohnett, M (1991) Involvement of the septohippocampal cholinergic system in representational memory. Brain Res 564:66-72
Messer Jr, W S; Ellerbrock, B R; Bohnett, M (1991) Regulation of muscarinic receptors by intrahippocampal injections of gallamine. Brain Res 564:73-8
Hoss, W; Woodruff, J M; Ellerbrock, B R et al. (1990) Biochemical and behavioral responses of pilocarpine at muscarinic receptor subtypes in the CNS. Comparison with receptor binding and low-energy conformations. Brain Res 533:232-8
Messer Jr, W S; Bohnett, M; Stibbe, J (1990) Evidence for a preferential involvement of M1 muscarinic receptors in representational memory. Neurosci Lett 116:184-9

Showing the most recent 10 out of 13 publications